282 related articles for article (PubMed ID: 31581580)
1. Sphingolipids as Potential Therapeutic Targets against Enveloped Human RNA Viruses.
Yager EJ; Konan KV
Viruses; 2019 Oct; 11(10):. PubMed ID: 31581580
[TBL] [Abstract][Full Text] [Related]
2. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.
Blaising J; Pécheur EI
Biochimie; 2013 Jan; 95(1):96-102. PubMed ID: 22884392
[TBL] [Abstract][Full Text] [Related]
3. Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review).
Rawat SS; Viard M; Gallo SA; Rein A; Blumenthal R; Puri A
Mol Membr Biol; 2003; 20(3):243-54. PubMed ID: 12893532
[TBL] [Abstract][Full Text] [Related]
4. Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses.
Martín-Acebes MA; Vázquez-Calvo Á; Saiz JC
Prog Lipid Res; 2016 Oct; 64():123-137. PubMed ID: 27702593
[TBL] [Abstract][Full Text] [Related]
5. Viral rewiring of cellular lipid metabolism to create membranous replication compartments.
Strating JR; van Kuppeveld FJ
Curr Opin Cell Biol; 2017 Aug; 47():24-33. PubMed ID: 28242560
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipids: Effectors and Achilles Heals in Viral Infections?
Schneider-Schaulies S; Schumacher F; Wigger D; Schöl M; Waghmare T; Schlegel J; Seibel J; Kleuser B
Cells; 2021 Aug; 10(9):. PubMed ID: 34571822
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.
Doerrbecker J; Friesland M; Riebesehl N; Ginkel C; Behrendt P; Brown RJ; Ciesek S; Wedemeyer H; Sarrazin C; Kaderali L; Pietschmann T; Steinmann E
Hepatology; 2014 Aug; 60(2):508-20. PubMed ID: 24771613
[TBL] [Abstract][Full Text] [Related]
8. More than one door - Budding of enveloped viruses through cellular membranes.
Welsch S; Müller B; Kräusslich HG
FEBS Lett; 2007 May; 581(11):2089-97. PubMed ID: 17434167
[TBL] [Abstract][Full Text] [Related]
9. Untargeted Lipidomics of Vesicular Stomatitis Virus-Infected Cells and Viral Particles.
Havranek KE; Reyes Ballista JM; Hines KM; Brindley MA
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062207
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the Host Lipid Landscape to Promote RNA Virus Replication: The Picornavirus Encephalomyocarditis Virus Converges on the Pathway Used by Hepatitis C Virus.
Dorobantu CM; Albulescu L; Harak C; Feng Q; van Kampen M; Strating JR; Gorbalenya AE; Lohmann V; van der Schaar HM; van Kuppeveld FJ
PLoS Pathog; 2015 Sep; 11(9):e1005185. PubMed ID: 26406250
[TBL] [Abstract][Full Text] [Related]
11. Viral infections and sphingolipids.
Schneider-Schaulies J; Schneider-Schaulies S
Handb Exp Pharmacol; 2013; (216):321-40. PubMed ID: 23563664
[TBL] [Abstract][Full Text] [Related]
12. N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.
Schweitzer CJ; Zhang F; Boyer A; Valdez K; Cam M; Liang TJ
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118118
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E, a Crucial Cellular Protein in the Lifecycle of Hepatitis Viruses.
Tréguier Y; Bull-Maurer A; Roingeard P
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409035
[TBL] [Abstract][Full Text] [Related]
14. Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses.
Villareal VA; Rodgers MA; Costello DA; Yang PL
Antiviral Res; 2015 Dec; 124():110-21. PubMed ID: 26526588
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipids in viral infection.
Schneider-Schaulies J; Schneider-Schaulies S
Biol Chem; 2015 Jun; 396(6-7):585-95. PubMed ID: 25525752
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids: modulators of HIV-1 infection and pathogenesis.
Rawat SS; Johnson BT; Puri A
Biosci Rep; 2005; 25(5-6):329-43. PubMed ID: 16307380
[TBL] [Abstract][Full Text] [Related]
17. y Human herpesvirus 6 envelope components enriched in lipid rafts: evidence for virion-associated lipid rafts.
Kawabata A; Tang H; Huang H; Yamanishi K; Mori Y
Virol J; 2009 Aug; 6():127. PubMed ID: 19689819
[TBL] [Abstract][Full Text] [Related]
18. Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication.
Hofmann S; Krajewski M; Scherer C; Scholz V; Mordhorst V; Truschow P; Schöbel A; Reimer R; Schwudke D; Herker E
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1041-1056. PubMed ID: 29885363
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural and biochemical basis for hepatitis C virus morphogenesis.
Falcón V; Acosta-Rivero N; González S; Dueñas-Carrera S; Martinez-Donato G; Menéndez I; Garateix R; Silva JA; Acosta E; Kourı J
Virus Genes; 2017 Apr; 53(2):151-164. PubMed ID: 28233195
[TBL] [Abstract][Full Text] [Related]
20. Lipid Droplets in Virus Replication.
Herker E
FEBS Lett; 2024 May; 598(10):1299-1300. PubMed ID: 38348563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
